2025
SJR Q2
JCR Q2 · 3
27 matched articles
SCIE
Journal detail
Expert Opinion on Drug Safety
- Publisher
- Taylor and Francis Ltd.
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
147403381744764X
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,86
- Quartile Q2
- H-Index 101
- Cites/doc 3,09
- Docs (3y) 476
- Cites (3y) 1.668
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 3
- 5Y JIF 3,2
- JCI 0,75
WoS indexes
- SCIE
Subject classification
Categories (SJR)
Areas
WoS categories
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 0,86 | 3 | 3,2 | 0,75 | Q2 | 101 |
| 2024 | Q2 | Q2 | 0,785 | 3,1 | 3,1 | 0,63 | Q3 | 96 |
| 2023 | Q1 | Q2 | 0,905 | 3 | 3,6 | 0,62 | Q3 | 96 |
| 2022 | Q2 | Q3 | 0,773 | 3,1 | 3,4 | 0,59 | Q3 | 96 |
| 2021 | Q1 | Q2 | 0,882 | 4 | 3,9 | 0,7 | Q2 | 96 |
| 2020 | Q1 | Q2 | 1,086 | 4,2 | 3,9 | 0,73 | Q2 | 96 |
| 2019 | Q1 | Q2 | 0,975 | 3,4 | 3,2 | 0,68 | Q3 | 96 |
| 2018 | — | Q2 | — | 3,2 | 3,2 | 0,62 | Q3 | — |
| 2017 | Q1 | Q2 | 1,112 | 3,2 | 3 | 0,61 | Q3 | 96 |
| 2016 | Q1 | Q1 | 1,297 | 3,4 | 3 | — | — | 96 |
| 2015 | Q1 | Q2 | 1,058 | 2,9 | 2,7 | — | — | 96 |
| 2014 | Q1 | Q2 | 0,992 | 2,9 | 2,8 | — | — | 96 |
| 2013 | Q1 | Q2 | 0,971 | 2,7 | 2,7 | — | — | 96 |
| 2012 | Q1 | Q2 | 1,003 | 2,6 | 2,4 | — | — | 96 |
| 2011 | Q1 | Q2 | 0,863 | 3 | 2,7 | — | — | 96 |
| 2010 | Q1 | Q2 | 0,857 | 2,6 | — | — | — | 96 |
| 2009 | — | Q2 | — | 2,5 | — | — | — | — |
| 2008 | — | Q2 | — | 3,1 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 169/356 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q3 | 134/352 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q3 | 136/354 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 152/278 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 115/279 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 94/276 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q3 | 88/271 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q3 | 88/267 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q3 | 82/261 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 63/257 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 83/255 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 91/255 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 93/256 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 103/261 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 77/261 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 100/252 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 107/237 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 64/219 |